As the U.S. population ages, there is growing concern about the loss of mental acuity associated with aging. Even small deficits are considered intermediates between normal cognitive attrition and severe conditions, such as Alzheimer?s disease. Mild cognitive impairment, which affects ~10% of those ?65 years, has a 56% conversion rate to dementia over 4 years. Because of dementia?s strong age dependence, merely delaying its onset could have a dramatic impact. A 5-year delay in the onset of Alzheimer?s disease would lead to ~4 million fewer cases in the U.S. The lack of biomarkers that reflect adverse exposures and preclinical effects dramatically limits opportunities for effective targeted prevention. Environmental exposures that augment systemic inflammation, such as ambient air pollution and metals, have been shown to hasten cognitive aging by as much as 5 years. We also recently showed that long term exposure to air pollution is associated with Alzheimer's disease incidence. Our goal is to identify new biomarkers that reflect environmental influences and predict the risk of impaired cognition. We will leverage experimental and clinical evidence on extracellular vesicles (EVs)?i.e., tiny membrane-bound vesicles actively released by tissue cells into the bloodstream?and of their bioactive cargo of micro (miRNAs) and long (lncRNAs) noncoding RNAs, which can signal inflammatory responses via their potent capacity for gene regulation. Animal and human studies have shown that environmental exposures induce the release of pro-inflammatory EVs into the bloodstream. Recent clinical data also show that changes in blood EV biomarkers precede and predict cognitive impairment. In particular, a small, but highly suggestive, case-control study identified EV-miRNAs in patients with Alzheimer?s disease, relative to controls, which were used?by means of a machine learning model (which we will also employ)?to identify early preclinical risk of Alzheimer?s disease. In the proposed studies, we will leverage the resources of well-phenotyped longitudinal cohorts. First, in the Normative Aging Study, we will access ready-to-use longitudinal collections of biospecimens, exposure data, and cognitive function measurements from four serial visits over 12 years of follow up. We hypothesize that environmental exposures to air pollution and metals, individually and as mixtures, will be associated with significantly higher numbers of EVs and differential EV size (Aim 1). We further hypothesize that the levels of and longitudinal changes in EV-encapsulated miRNAs and lncRNAs reflect current and past environmental exposures and predict subsequent cognitive decline (Aim 2). Finally, we will use machine learning and mediation analysis to determine the roles of circulating EVs and their noncoding RNA cargo on the biological pathways linking environmental exposures to cognitive decline (Aim 3). We will validate all findings in the KORA cohort, which has similar design and data. Our work may yield a model for other potentially modifiable risk factors for impaired cognition and Alzheimer?s disease, as well as for additional age-related diseases.

Public Health Relevance

IMPACT The limited availability of predictors of cognitive decline is a critical gap identified in the 2015 DHHS priorities that, if not addressed soon, will leave the U.S. population unprotected from the current exponential growth of socioeconomic burden from impaired cognition in older individuals. The proposed research will identify novel biomarkers that accurately reflect adverse environmental influences and detect the beginnings of cognitive decline before it manifests fully. Due to the central roles that EVs play in inflammation and tissue signaling, this study could provide a model that can be extended to additional risk factors of cognitive decline, as well as to other chronic diseases of aging.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES027747-04
Application #
9981740
Study Section
Neurological, Aging and Musculoskeletal Epidemiology (NAME)
Program Officer
Tyson, Frederick L
Project Start
2017-09-30
Project End
2022-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
4
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Harvard University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Wu, Alexander C; Allen, Joseph G; Coull, Brent et al. (2018) Correlation over time of toenail metals among participants in the VA normative aging study from 1992 to 2014. J Expo Sci Environ Epidemiol :
Gao, Xu; Colicino, Elena; Shen, Jincheng et al. (2018) Accelerated DNA methylation age and the use of antihypertensive medication among older adults. Aging (Albany NY) 10:3210-3228